赛升药业：股东马丽已减持1.33%

Group 1 - The controlling shareholder's actual controller, Ma Li, plans to reduce holdings from October 21, 2025, to January 20, 2026, by no more than 9.6333 million shares, accounting for 2% of the company's total share capital [1] - As of January 20, 2026, Ma Li has reduced holdings by 6.41 million shares, which is 1.33% of the total shares, through centralized bidding and block trading [1] - The reduction included selling 4.81 million shares at 12.07 yuan per share from November 18, 2025, to January 14, 2026, and 1.6 million shares at 10.36 yuan per share from January 13 to January 19, 2026 [1] Group 2 - Liu Shuqin has not reduced any holdings, and the reduction plan period has expired [1]